http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2047620-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da8d2207c56a02ce65b6b7ee25f89a31 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 |
| filingDate | 1990-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61015b1c4381a4243f83b4fccf460864 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b02cc2bf9478d30ce084ca2a38a0753 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f2204bbc2b41abce3f61f36cb1a6a2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62003ecae6b87524afb6819939f6c4e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f71cbe251a83c824712e03c9a20053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_322d70b194ca5007ac910dfbc36cc4bd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20eac82be59ac07f787f11296494cbc6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e147d250935562d059d931031ea7c8f1 |
| publicationDate | 1995-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2047620-C1 |
| titleOfInvention | Method of flavine-adenine dinucleotide purification |
| abstract | FIELD: medicine. SUBSTANCE: product: flavine-adenine dinucleotide (FAD). The yield is 77.2% content of basic substance is 99.5% Reagent 1: FAD. Reagent 2: diethylaminoethyl-spherone in Cl - -form, ionic strength is 0.05-0.5 M and pH 3-5, and "Polysorb C". Reaction conditions: aqueous solution of FAD is passed through the column with adsorbents. Impurities were desorbed with buffer containing NaCl and CH 3 CO 2 Na, FAD is desorbed with NaCl at ionic strength 0.1-0.5 M, eluate is desalted and concentrated by 10-20-fold on the "Polysorb C". Crystalline FAD is isolated by precipitation with ethanol. FAD is used as pharmaceutical preparation for treatment patients with glaucoma, psoriasis, seborrhea, hereditary hemolytic anemia. EFFECT: improved method of purification. 1 tbl |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100352827-C |
| priorityDate | 1990-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.